Abstract
CYCLOPHOSPHAMIDE (I), the widely used antitumour agent synthesized by Arnold and Bourseaux1, has to be biologically converted into an active compound for it to be effective in vivo1–7. This activation takes place preferentially in the liver4, more specifically in its microsomes in the presence of NADPH and oxygen6 by means of the mixed function oxidase system7,8. Brock and Hohorst7 assumed that the cyclophosphamide ring opened by N-dealkylation or O-dealkylation to give primary active metabolites. Norpoth et al.9 favoured O-dealkylation as the mechanism leading to the production of the active transformation product.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
We are sorry, but there is no personal subscription option available for your country.
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Arnold, H., and Bourseaux, F., Angew Chem., 70, 539 (1958).
Arnold, H., Bourseaux, F., and Brock, N., Naturwissenschaften, 45, 64 (1958).
Brock, N., Acta Union Intern. Contra Cancrum, 16, 552 (1960).
Foley, G. E., Friedman, O. M., and Drolet, B. P., Cancer Res., 21, 57 (1961).
Philips, F. S., Sternberg, S. S., Cronin, A. P., and Vidal, P., Cancer Res., 21, 1577 (1961).
Brock, N., and Hohorst, H. J., Arzneim. -Forsch., 13, 1021 (1963).
Brock, N., and Hohorst, H. J., Cancer, 20, 900 (1967).
Cohen, J. L., and Jao, J. Y., J. Pharmacol. Exp. Ther., 174, 206 (1970).
Norpoth, K., Golovinsky, E., and Rauen, H. M., Hoppe-Sevier's Z. Physiol. Chem., 351, 377 (1970).
Alarcon, R. A., Arch. Biochem. Biophys., 137, 365 (1970).
Li, Ph. K., and Zeller, E. A., Abstracts of Papers, 160th National Meeting, American Chemical Society, Division of Biol. Chem., Abstract No. 9, Chicago, Illinois, 1970.
Kimes, B. W., and Morris, D. R., Biochim. Biophys. Acta, 228, 223 (1971).
Tabor, C. W., Tabor, H., and Bachrach, U., J. Biol. Chem., 239, 2194 (1964).
Gillette, J. R., Adv. Pharmacol., 4, 219 (1966).
Udenfriend, S., Clark, C. T., Axelrod, J., and Brodie, B. B., J. Biol. Chem., 208, 731 (1954).
Staudinger, Hj., Kerekjarto, B., Ullrich, V., and Zubrzycki, Z., Symposium on Oxidases and Related Oxidation Reduction Systems, 2, 815 (Academic Press, New York, 1965).
Breslow, R., and Lukens, L. N., J. Biol. Chem., 235, 292 (1960).
Alarcon, R. A., Anal. Chem., 40, 1704 (1968).
Cohen, I. R., and Altshuller, A. P., Anal. Chem., 33, 726 (1961).
Allen, C. F. H., J. Amer. Chem. Soc., 52, 2955 (1930).
Alarcon, R. A., Arch. Biochem. Biophys., 106, 240 (1964).
Ernster, L., Siekevitz, P., and Palade, G. E., J. Cell. Biol., 15, 541 (1962).
Friedman, O. M., Cancer Chemotherapy Rep., 51, 327 (1967).
Conney, A. H., Pharmacol. Rev., 19, 317 (1967).
Hohorst, H. J., Ziemann, A., and Brock, N., Arzneim. -Forsch., 15, 432 (1965).
Boesen, E., and Davis, W., in Cytotoxic Drugs in the Treatment of Cancer (Arnold, London, 1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ALARCON, R., MEIENHOFER, J. Formation of the Cytotoxic Aldehyde Acrolein during in vitro Degradation of Cyclophosphamide. Nature New Biology 233, 250–252 (1971). https://doi.org/10.1038/newbio233250b0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/newbio233250b0
This article is cited by
-
Progress in the Development of Reaction-Based Sensors for Detection of Acrolein in Biological Samples
BioNanoScience (2016)
-
Cyclophosphamide-impaired regulation of hepatic heme metabolism
Experientia (1984)
-
Does acrolein contribute to the cytotoxicity of cyclophosphamide?
Journal of Cancer Research and Clinical Oncology (1980)
-
Ultrastructural autoradiographic study of the intracellular fixation of3H-acrolein
Experientia (1976)
-
The production of pulmonary oedema in mice by cyclophosphamide and iodide
Agents and Actions (1974)